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Background: Electroconvulsive therapy (ECT) is the most effective treatment option for major depressive
disorder, so understanding whether its clinical effect relates to structural brain changes is vital for
current and future antidepressant research.
Objective: To determine whether clinical response to ECT is related to structural volumetric changes in
the brain as measured by structural magnetic resonance imaging (MRI) and, if so, which regions are
related to this clinical effect. We also determine whether a similar model can be used to identify regions
associated with electrode placement (unilateral versus bilateral ECT).
Methods: Longitudinal MRI and clinical data (Hamilton Depression Rating Scale) was collected from 10
sites as part of the Global ECT-MRI research collaboration (GEMRIC). From 192 subjects, relative changes
in 80 (sub)cortical areas were used as potential features for classifying treatment response. We used
recursive feature elimination to extract relevant features, which were subsequently used to train a linearud University Medical Center
ds.
P.C.R. Mulders).
r Inc. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
P.C.R. Mulders et al. / Brain Stimulation 13 (2020) 696e704 697classifier. As a validation, the same was done for electrode placement. We report accuracy as well as the
structural coefficients of regions included in the discriminative spatial patterns obtained.
Results: A pattern of structural changes in cortical midline, striatal and lateral prefrontal areas dis-
criminates responders from non-responders (75% accuracy, p < 0.001) while left-sided mediotemporal
changes discriminate unilateral from bilateral electrode placement (81% accuracy, p < 0.001).
Conclusions: The identification of a multivariate discriminative pattern shows that structural change is
relevant for clinical response to ECT, but this pattern does not include mediotemporal regions that have
been the focus of electroconvulsive therapy research so far.
© 2020 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Introduction
Major depressive disorder is a leading cause of disability
worldwide and one of the biggest challenges the field of mental
health faces today [1]. High prevalence and the fact that up to a
third of patients suffering from depression fail to respond to con-
ventional pharmaco- or psychotherapy [2] has renewed scientific
interest in electroconvulsive therapy (ECT), which achieves a fast
antidepressant response in a majority of these treatment-resistant
patients [3]. Understanding the mechanisms through which ECT
achieves its remarkably strong clinical effect could provide critical
biological markers to advance both established and emerging an-
tidepressant therapies. To this end, the Global ECT-MRI Research
Collaboration (GEMRIC) was founded to pool data from multiple
sites to increase power and enable analyses that cannot be per-
formed on smaller samples [4].
Over the past years an emerging body of literature has investi-
gated ECT-related changes in brain structure and, to a lesser degree,
function. A recent explorative GEMRIC analysis of structural change
reported volumetric increases in 79 of 84 grey matter regions,
which linked to electrode placement (uni- or bilateral) and number
of ECTs, but not to clinical outcome [5]. While others have also
observed widely distributed effects throughout the brain [6e10],
several regions have been more consistently implicated as relevant
to ECT’s antidepressant effects. Stimulated by translational studies
on neurotrophic effects of ECT, medial temporal lobe structures
including the hippocampus and amygdala have been subject to a
number of investigations [7,11e13]. Nearly all these studies report
significant volume increases after ECT, which has been confirmed
through meta-analyses [14,15]. In a recent GEMRIC mega-analysis
this increase in hippocampal volume after ECT was again related
to both electrode placement and number of ECT sessions admin-
istered [16], but while translational and human studies have sug-
gested a link between hippocampal volume and behavioral changes
[17e21], no relation to treatment outcome was established.
Furthermore, follow-up studies have found the increase in medial
temporal lobe volume to be transient in nature [22,23]. Other areas
of interest reported across multiple studies are the anterior
cingulate cortex (ACC) [8,10,24,25], the insula [26,27] and the
striatum [6,27,28]. Critically, all of these regions are also affected in
patients suffering from depression, with recurrent or treatment-
resistant patients being typically more affected [29e32].
So, although ECT induces prominent and widespread structural
changes, it remains unclear whether these changes are related to its
antidepressant properties [15,16,33]. A lack of reproducible links
between structural changes and clinical efficacy of ECT could
indicate that either treatment response to ECT is not related to any
structural changes in the brain or that samples and methods used
so far have been underpowered to detect a statistically and clini-
cally relevant relationship. An important limitation here is that
most studies have employed a univariate approach, attempting to
link clinical improvement to structural change in a single region,while both depression and ECT are known to affect various inter-
acting regions and circuits throughout the brain which makes it
unlikely that response depends on changes in a single region
[30,34]. To address this issue, we use the aforementioned GEMRIC
dataset to investigate whether 1) patterns of structural changes in
the brain induced by ECTare related to clinical response and 2) if so,
which regions in these patterns are most relevant for treatment
response. We employ multivariate discriminant analysis to test
whether a model that can discriminate responders from non-
responders on the basis of volumetric changes detected with
structural MRI can be developed. Such a model provides both the
flexibility of not needing strong prior assumptions on where clin-
ically relevant effects happen as well as the appropriate multivar-
iate linear framework allowing us to identify which regions
contribute to ECT’s remarkable clinical effect.
Methods
Participants and neuroimaging data
We use data from the Global ECT-MRI Research Collaboration
(GEMRIC), a multi-site initiative pooling clinical and neuroimaging
data of ECT patients. Informed consent was obtained from all pa-
tients. For our analysis we use data from 10 GEMRIC sites for a total
of 237 depressed subjects who had received either right unilateral
or bilateral ECT (or both) with available imaging and clinical data
(depression severity, either 17-item Hamilton Depression Rating
Scale (HAM-D) or Montgomery-Asberg Depression Rating Scale
converted to HAM-D through the method described by Heo et al.
[35]). For a detailed description of GEMRIC including site-specific
ECT procedures, image acquisition and common data processing
methods, we refer to Oltedal et al. [4]. In short, the data includes
patients with a depressive episodewhowere eligible to receive ECT,
most typically after failure to respond to conventional psycho- and
pharmacotherapy. There are some regional differences in ECT
procedure used among the sites in our sample, including electrode
placement which varies between right unilateral only, bilateral
only or initial right unilateral with a switch to bilateral after non-
response. For each subject, response was defined as a decrease of
50% or more on HAM-D score.
T1-weighted MRI volumes with a minimum resolution of
1.3 mm3 were acquired before and after ECT using either a 1.5T or
3T scanner. Imaging data were analyzed using a common pipeline.
Images were corrected for scanner-specific gradient nonlinearity
[36], registered to a common atlas and resampled to 1 mm3 reso-
lution. FreeSurfer 5.3 was used to obtain measures of cortical and
subcortical volumes [37e39]. Longitudinal change was estimated
using Quarc [40], for a total of 80 longitudinal features per subject
(see supplementary information for the full feature list). Due to the
lack of robust clinically relevant effects found in ECT and the
widespread effect ECT has on brain volume we did not select only
regions-of-interest.
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80 different regions were tested for association with treatment
response by means of a penalized Linear Discriminant Analysis
(LDA). Because of sensitivity to outliers in feature selection, we
excluded patients that were extreme outliers (>3 standard de-
viations) on any of the 80 imaging features for a final sample of 192
subjects. A leave-one-subject out design, using volume normali-
zation and recursive feature elimination with internal cross-
validation, provided 192 model estimates of features relevant for
discrimination between responders and non-responders [41].
Due to the large number of features compared to the number of
subjects in the smallest group, we observed high variance in the
number of relevant brain areas selected at each fold. Consequently,
to get a unique set of relevant features we removed features that
were selected less than ~1% of all models (2 models). To validate the
quality of the set of selected brain areas, we used these remaining
features to train a linear classifier (LDA, least squares fit with
automatic shrinkage estimation) which provided us with the
learned model accuracy The performance of this model was then
evaluated by means of permutation testing (1000 permutations,
where within each iteration the labels are randomized and our
model is tested against the “chance” model) [42]. Due to the large
number of features in contrast to our smallest group (72 non-
responders), we were unable to select features, train and test the
model in independent samples. As such, while our sample is
diverse and contains data from various research sites, the model
accuracy is an indication of picking up relevant within-sample
signal, rather than the estimated accuracy should it be applied to
an out-of-sample dataset. Using both leave-one out and stratified
10-fold cross-validation gives insight into how the model accuracy
changes based on a different split of the data.
Because we use a linear model, we can interpret the weights from
the classifier by transforming them to structural coefficients as
described by Haufe et al. [43]. This transform helps us discernweights
that contribute to classification from those included to cancel noise
that obscures the underlying relevant discriminative properties. These
structural coefficients are more informative for the classification of
interest the further they are from zero, while their sign indicates how
values are indicative of belonging to one class over the other. These
coefficients together make up a discriminative map that indicates
regional predictive power for clinical improvement.
We used this analysis to detect which regions are related to
treatment response to answer our main research question. To
assess how our model is affected by variables that are inherently
linked to treatment trajectory and effect, we also test the model
taking into account age, sex, number of ECT sessions and electrode
placement by regressing these variables out of the imaging data
before training the classifier. We also test for site-differences by
training the classifier excluding each site and predicting treatment
response in the site left out. Finally, as an additional validation
strategy for our analysis, we apply the same method to obtain a
discriminative map for regions associated with site of electrode
placement (defined as having received either right unilateral
treatment only (RUL) versus bilateral treatment only or unilateral
followed by bilateral treatment (BL)). All analyses were performed
in python using the scikit-learn toolkit [44] and results were
visualized using a template [45].
Results
Demographics
Key demographics are presented in Table 1. Notably, there is a
clear treatment effect for ECT, which separates responders fromnon-responders, and these groups also differ in age (p < 0.001), but
not sex or baseline clinical score. As expected, non-responders have
a higher likelihood of receiving bilateral ECT, as a switch from
unilateral to bilateral treatment is common practice after initial
non-response. Within our sample 62.5% were responders and 61%
received exclusively unilateral ECT while the other 39% received
only bilateral ECT (n ¼ 39) or switched to bilateral ECT after non-
response to unilateral treatment (n ¼ 36).General effects
In line with earlier work [5], all features included in the analysis
showed an average positive increase in volume, ranging from 0.2 to
5.1%. This increase is more pronounced in lateral and medi-
otemporal regions (amygdala, hippocampus, entorhinal cortex,
temporal pole), while changes in parietal and occipital regionswere
relatively small (see Supplementary Table S1 for baseline and
changes per region).Feature selection and analysis
Treatment response
The feature selection procedure over 192 iterations selected on
average 8.9 features (±2.4 features, median 8). 18 features were
selected bymore than 1% of all models (see Supplementary Table S2
for probabilities). Using these features, we trained a linear classifier
(LDA), which performed with an accuracy of 75% to classify treat-
ment response (sensitivity 84%, specificity 60%), which is signifi-
cantly better than chance (p < 0.001; stratified 10-fold accuracy
72%, p < 0.001; split-half accuracy 66%, p < 0.001). Per-site accuracy
scores are presented in Supplementary Table S3. The discriminative
pattern remained significant after regressing out age, sex, number
of ECT sessions and electrode placement (p < 0.001, Supplementary
Table S4).
The relevant features, ranked by their structural coefficients
[43], are presented in Fig. 1 and Table S5. From highest to lowest
importance, the contributing regions are the right precuneus (0.27),
right putamen (0.26), left rostral ACC (0.21), right supra-
marginal gyrus (0.17), left rostral middle frontal gyrus (0.16), right
caudal ACC (0.16), right rostral ACC (0.11), right fusiform gyrus
(0.11), left precuneus (0.11), left middle temporal cortex (0.11), left
supramarginal gyrus (0.09), right frontal pole (0.06), left entorhinal
cortex (0.06), right precentral cortex (0.05), left banks of the
superior temporal sulcus (0.04), left isthmus cingulate (0.02),
left fusiform gyrus (0.02) and right parahippocampal cortex (0.01).
The signs of the coefficients indicate that larger increases in volume
in the bilateral precuneus, supramarginal gyrus and right caudal
ACC are more indicative of being a responder to ECT, while larger
increases in right putamen, left rostral middle frontal gyrus and
rostral ACC are more indicative of being a non-responder.
As is evident by the discriminative map presented, while all
regions add classification accuracy, some regions are highly rele-
vant for discriminating responders from non-responders as repre-
sented in high absolute structural coefficients (right precuneus,
right putamen, right supramarginal, left rostral ACC, left rostral
middle frontal gyrus, right caudal ACC), while other regions are
almost exclusively cancelling noise to uncover the relevant signal
(structural coefficient close to zero; left fusiform gyrus, right par-
ahippocampal cortex, left isthmus cingulate, left banks of the su-
perior temporal sulcus, right precentral cortex).
Table 1
Demographics of patients included in the data analysis.
Relevant subject demographics and comparison between responders and non-responders to treatment. Abbrevations: RUL: right unilateral ECTonly; BL: bilateral ECT; HAM-D:
Hamilton Rating Scale for Depression. *independent t-test or chi-squared.
full sample (n ¼ 192) responders (n ¼ 120) non-responders
(n ¼ 72)
responders vs. non-responders*
mean std mean std mean std p
Age 53.9 15.5 56.9 13.78 48.8 16.81 0.00075
Sex (m/f) 74/118 n.a. 47/73 n.a. 27/45 n.a. 0.818
Laterality (RUL/BL) 117/75 n.a. 81/39 n.a. 36/36 n.a. 0.016
HAM-D pre 25.3 6.5 26.0 6.6 24.2 6.2 0.061
HAM-D post 10.9 8.4 5.7 4.1 19.7 6.2 8.10E-33
HAM-D change 14.4 10.0 20.3 6.8 4.5 5.5 2.94E-39
No. ECT sessions (n ¼ 185) 12.4 4.6 11.9 4.5 13.2 4.6 0.057
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Feature selection for electrode placement revealed 31 features
of interest. The linear classifier trained using these features classi-
fied electrode placement with an accuracy of 81% (sensitivity 90%,
specificity 68%, p < 0.001). The full set of features and their struc-
tural coefficients are presented in Fig. 2 (and Supplementary
Table S6). Most notably, the obtained discriminative map shows a
strong contribution of left-sided regions known to be affected
differently by electrode placement: the left amygdala (0.28), left
hippocampus (0.21) and left entorhinal cortex (0.24). LargerFig. 1. Discriminative map associated with treatment response to electroconvulsive the
Map representing absolute structural coefficients of the discriminative pattern separating r
probability of being a responder, a larger increase in blue areas corresponds to higher prob
alization was created using code available through GitHub (www.github.com/roscha). (For in
Web version of this article.)changes in these regions are indicative of having received bilateral
over unilateral ECT.
Discussion
Understanding the neural mechanisms underlying the most
potent antidepressant treatment available is an important step
towards advancing current and novel treatment strategies, as well
as reducing stigma surrounding psychiatric disorders and their
treatments. As such, information on whether structural changes in
the brain are relevant for treatment response is a simple yet
fundamental question that needs to be addressed. We show, byrapy and corresponding structural coefficients.
esponders from non-responders. A larger increase in red areas corresponds to higher
ability of being a non-responder. Abbreviations: ACC: anterior cingulate cortex. Visu-
terpretation of the references to colour in this figure legend, the reader is referred to the
Fig. 2. Discriminative map associated with electrode placement and corresponding structural coefficients.
Map representing absolute structural coefficients of the discriminative pattern separating patients receiving unilateral from those receiving bilateral ECT. A larger increase in red
areas corresponds to higher probability of having received bilateral ECT, a larger increase in blue areas corresponds to higher probability of having received only unilateral ECT.
Visualization was created using code available through GitHub (www.github.com/roscha). (For interpretation of the references to colour in this figure legend, the reader is referred
to the Web version of this article.)
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changes in the brain is associated with clinical response to ECT.
Regions identified as contributing to response are located in
cortical midline, striatal and lateral prefrontal areas implicated in
the pathophysiology of depression. In addition, we dissociate re-
gions related to treatment response from those related to site of
electrical stimulation by showing that the type of ECT used (uni-
lateral or bilateral) can be identified by a discriminative map that
incorporates unilateral medial temporal regions that are known to
be affected by ECT [46]. Below, we will discuss the significance of
these findings.
To interpret our results in the light of earlier work, it is impor-
tant to distinguish that our multivariate model is not directly
comparable with the majority of univariate analyses; none of the
regions associated with treatment response or electrode placement
does so independently. Instead, multivariate analysis takes the full
pattern of structural changes into account and allows us to
discriminate responders from non-responders. Furthermore it is
able to discriminate bilateral from unilateral ECT which, given the
clinical discussion on preference of unilateral versus bilateral
stimulation, could aid in uncovering neuroimaging correlates of
different approaches to ECT. In addition to the multivariate inter-
pretation, the sign of the structural coefficients as derived from the
featureweights relates to increases in volume, within the pattern as
a whole, being either indicative of response (bilateral precuneus,
supramarginal gyrus and right caudal ACC) or non-response (right
putamen, rostral ACC, left rostral middle frontal gyrus).We observe that the predominantly bilateral regions contrib-
uting significantly to classification of treatment response are
consistent with other work indicating aberrant structure and/or
function in cortico-limbic and cortico-strial systems in depression.
In fact, all of the discriminative regions have previously been
demonstrated to show changed (mostly decreased) volume
[29,30,32,47,48] and dysconnectivity within large-scale functional
networks [49e52] in depression. Several of these regions are well
established in the context of depression and warrant additional
consideration here.
The precuneus is part of the posterior default mode network and
is associated with self-related processing and episodic memory
retrieval [53,54]. There is evidence of decreased volume in the
precuneus in first-episode depression [55], and altered function or
functional connectivity during rest [55e58] and self-related judg-
ment [59]. Preliminary evidence also links changes in precuneus
activity or network connectivity to treatment with antidepressants
[60], psychotherapy [61] and ECT [56]. The anterior cingulate cortex
is a core region within the anterior default mode network [62],
showing decreased volume [29,30,32] and typically increased
activation during rest in depressed patients [62,63], which has been
suggested as a biomarker for treatment response to various forms
of biological treatment up to deep brain stimulation [62,64].
Importantly, activity within the anterior cingulate cortex appears to
be highly context-sensitive, in line with its function in self-
referential emotional processing and the attribution of valence to
external stimuli [65e67]. The left rostral middle frontal cortex
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cognitive-executive network, a functional hub that exerts top-
down cognitive control over cortical midline and limbic regions, a
balance that has been shown to be dysfunctional in depression
[68e70]. Antidepressant effects have been found in this region in
response to antidepressants [71] and ECT [72], and left dorsolateral
prefrontal cortex is currently the primary target for transcranial
magnetic stimulation for depression. A recent study has also shown
how various lesions in a brain circuit centered around the dorso-
lateral prefrontal cortex link to depression [73]. Finally, the
discriminative relevance of the putamen is consistent with reports
of reduced putamen volume in depression [32,55] and the rele-
vance of the striatum in the context of depression and as a potential
marker for treatment response [64]. Taken together our finding that
these regions, which are critical to our discriminative pattern, are
already established as key depression hubs, potential biomarkers of
treatment response, and/or the target for other neuromodulation
techniques [74], gives further credence to our method detecting
relevant response-related effects.
We also report that structural changes in the main regions un-
der investigation in the context of ECT, the hippocampus and
amygdala, are not included in the pattern associated with treat-
ment response. This is in line with a lack of any reproducible
findings linking volumetric changes in these regions to clinical ef-
fects in either depression or ECT [14,16]. One possible explanation is
that not the hippocampus as a whole, but rather specific subfields
within the hippocampus such as the dentate gyrus (or granule cell
layer) are relevant for clinical response [75,76]. Medial temporal
regions also appear differentially engaged by unilateral or bilateral
ECT, as is evident by unilateral medial temporal changes being
associated with electrode placement. Recent work within GEMRIC
has shown how structural changes are affected by local electric
fields [77], which could further explain differences between stim-
ulation methods. This is consistent with differences in cortical
volume [78], cerebral blood flow [11] and seizure propagation [79]
between unilateral and bilateral ECT. More expansive engagement
of medial temporal regions in bilateral ECT might be related to the
higher occurrence of cognitive side-effects in bilateral versus uni-
lateral ECT [80,81]. Overall, no single region was in itself predictive
of treatment response or electrode placement at the level of the
multivariate solution, corresponding to our current understanding
of depression as a multi-systems level disorder encompassing
large-scale brain networks and with the large-scale engagement of
the brain in ECT [82]. As such, a multivariate approach appears
more suitable to further conceptualize neuroimaging markers of
antidepressant response.
In light of their expansiveness and the timeframe of structural
changes induced by ECT, there has been much discussion on their
biological nature. While some have suggested they could be
attributable to edema caused by the electrical stimulus itself, this
notion is not supported by studies using T2-relaxometry to detect
significant fluid shifts [12,83,84]. A prominent hypothesis posits
that ECT combats depression by inducing neurotrophic effects [85],
in line with volumetric decreases in depression [30,31]. Indeed,
preclinical studies of ECT have found support for neurogenesis
[18,86], angiogenesis [87], glial cell proliferation [88] and increased
dendritic complexity and synaptogenesis [89]. Certainly, in ECT,
neurogenesis is not the only factor at play as neurogenesis is slow
compared to ECT-induced volume changes and is limited to the
dentate gyrus and subventricular zone, while ECT-induced volume
changes occur across the brain. In patients, support for neuroplastic
effects is represented by increases in plasma and serum brain-
derived neurotrophic factor (BDNF) and vascular endothelial
growth factor after ECT [90,91] but while persistent depression has
been associated with decreased peripheral BDNF, its prognosticvalue may be limited [92e94]. Furthermore, while volumetric in-
creases after ECT become more pronounced as the number of ECT
sessions increases, they revert back to pre-treatment levels after 6
[22,23,95] and 12 months [23]. Consistent with the lack of a clear
relation of ECT-induced volumetric changes to clinical efficacy,
their return to pre-treatment levels has not been found to be
related to either relapse of depression or recovery from cognitive
side-effects [22,23,95].
Taken together, it is likely that not one but multiple neuroplastic
systems are engaged during and after ECT and operate on varying
timescales to affect both short and longer-term changes in struc-
ture and function. How these neuroplastic changes can help to
overcome depression is still largely unknown, but one possibility is
that this forging or restoring of connections within large scale
networks that are dysfunctional in depression helps to overcome
depressogenic pathways. Better characterization of changes over
time, as opposed to only before and after treatment, their relation
to both response and relapse, and integration of structural and
functional imaging could be beneficial in understanding these
effects.
Despite our promising results there are some limitations that
need addressing. While we use both a statistical and biological
validation for the method used, we are still limited by trying to
optimize covariance space of 80 features in a sample with 72 non-
responders, which restricts us to selecting the relevant features and
building the classifier using the same data while ideally those
processes would be split. Although we validate our discriminative
pattern by cross-validation and our methods by applying it to well-
known unilateral effects (site of electrode placement), there is still a
risk of overfitting the feature selection to our specific dataset. As
such, accuracy of the model should be interpreted as indicative of
within-sample performance; additional work should confirm
whether this pattern holds in independent samples. Furthermore,
the FreeSurfer parcellation, while robust and sufficiently validated,
remains an average representation of more localized variations in
structure. Finer grained parcellations could provide more insight
into the areas identified in this paper here or areas whose relevance
is now undervalued by their inclusion into a larger region, such as
the dentate gyrus [75,76]. In addition, subject-specific information
such as stimulation parameters other than electrode placement
might also affect structural changes differently, which we were
unable to take into account. Finally, while multivariate analyses are
powerful in detecting relevant patterns, with an increase in the
number of relevant regions their interactions become more com-
plex to interpret.
Conclusion and future
In conclusion, we show that structural brain changes are
indicative of treatment response to ECT, but not in the regions that
are typically investigated (medial temporal areas). Instead, we
observe this response to be related to cortical midline, striatal and
lateral prefrontal areas implicated in the etiology of depression and
its treatments. We show the power of collaborative efforts to tackle
questions that would otherwise remain elusive and the power of
explorative multivariate approaches when linking brain and
behavior. Future studies could elaborate on our work, including
replication in larger or independent samples, as well as integrating
structural and functional data to reach a more comprehensive un-
derstanding of the mechanisms underlying antidepressant
response.
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